MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bbadis.2019.05.021

Медицинская библиотека · Biochimica et biophysica acta. Molecular basis of disease · 2019

5-Lipoxagenase deficiency attenuates L-NAME-induced hypertension and vascular remodeling.

Chen Jia-Xiang, Xue Kun-Yue, Xin Juan-Juan, Yan Xin, Li Ru-Li, Wang Xiao-Xiao, Wang Xu-Lei, Tong Ming-Ming, Gan Lu, Li He, Lan Jie, Li Xue, Zhuo Cai-Li, Li Ling-Yu, Deng Zi-Jie, Zhang Heng-Yu, Jiang Wei

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Abnormalities of the L-arginine-nitric oxide pathway induce hypertension. 5-Lipoxygenase (5-LO) is the key enzyme involved in synthesis of leukotrienes (LTs). However, whether nitricoxide synthase dysfunction induces hypertensive vascular remodeling by regulating 5-LO activity and its downstream inflammatory metabolites remains unknown.

METHODS AND

RESULTS

Six-week L-NAME treatment significantly induced hypertension and vascular remodeling in both wild-type (WT) and 5-LO-knockout (5-LO-KO) mice, and blood pressure in caudal and carotid arteries was lower in 5-LO-KO than WT mice with L-NAME exposure. On histology, L-NAME induced less media thickness, media-to-lumen ratio, and collagen deposition and fewer Ki-67-positive vascular smooth muscle cells (VSMCs) but more elastin expression in thoracic and mesenteric aortas of 5-LO-KO than L-NAME-treated WT mice. L-NAME significantly increased LT content, including LTB4 and cysteinyl LT (CysLTs), in plasma and neutrophil culture supernatants from WT mice. On immunohistochemistry, L-NAME promoted the colocalization of 5-LO and 5-LO-activating protein on the nuclear envelope of cultured neutrophils, which was accompanied by elevated LT content in culture supernatants. In addition, LTs significantly promoted BrdU incorporation, migration and phenotypic modulation in VSMCs.

CONCLUSION

L-NAME may activate the 5-LO/LT pathway in immune cells, such as neutrophils, and promote the products of 5-LO metabolites, including LTB4 and CysLTs, which aggravate vascular remodeling in hypertension. 5-LO deficiency may protect against hypertension and vascular remodeling by reducing levels of 5-LO downstream inflammatory metabolites.

Для цитирования: Chen Jia-Xiang, Xue Kun-Yue, Xin Juan-Juan, Yan Xin, Li Ru-Li, Wang Xiao-Xiao, Wang Xu-Lei, Tong Ming-Ming, Gan Lu, Li He, Lan Jie, Li Xue, Zhuo Cai-Li, Li Ling-Yu, Deng Zi-Jie, Zhang Heng-Yu, Jiang Wei. 5-Lipoxagenase deficiency attenuates L-NAME-induced hypertension and vascular remodeling.. Biochimica et biophysica acta. Molecular basis of disease. 2019. DOI: 10.1016/j.bbadis.2019.05.021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.